HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ana Perez-Castillo Selected Research

Type 7 Cyclic Nucleotide Phosphodiesterases

2/2020Phosphodiesterase 7 Regulation in Cellular and Rodent Models of Parkinson's Disease.
6/2015Phosphodiesterase 7 inhibition induces dopaminergic neurogenesis in hemiparkinsonian rats.
3/2014Crosstalk between phosphodiesterase 7 and glycogen synthase kinase-3: two relevant therapeutic targets for neurological disorders.
4/2012Effect of phosphodiesterase 7 (PDE7) inhibitors in experimental autoimmune encephalomyelitis mice. Discovery of a new chemically diverse family of compounds.
1/2012Neuroprotective efficacy of quinazoline type phosphodiesterase 7 inhibitors in cellular cultures and experimental stroke model.
2/2011Phosphodiesterase 7 inhibition preserves dopaminergic neurons in cellular and rodent models of Parkinson disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ana Perez-Castillo Research Topics

Disease

7Neurodegenerative Diseases (Neurodegenerative Disease)
08/2021 - 06/2005
7Brain Injuries (Brain Injury)
10/2016 - 04/2008
6Parkinson Disease (Parkinson's Disease)
02/2020 - 06/2005
5Hypothyroidism
01/2017 - 05/2008
4Brain Diseases (Brain Disorder)
01/2017 - 05/2007
4Breast Neoplasms (Breast Cancer)
11/2009 - 08/2003
3Alzheimer Disease (Alzheimer's Disease)
01/2020 - 06/2005
3Neuroinflammatory Diseases
02/2019 - 06/2005
2Glioblastoma (Glioblastoma Multiforme)
02/2015 - 11/2010
2Nervous System Diseases (Neurological Disorders)
03/2014 - 09/2012
2Stroke (Strokes)
02/2012 - 01/2012
2Seizures (Absence Seizure)
07/2010 - 12/2009
2Neuroblastoma
08/2003 - 02/2002
1Disease Progression
02/2019
1Neoplasm Metastasis (Metastasis)
02/2015
1Encephalitis (Encephalitis, Rasmussen)
02/2015
1AIDS-Related Complex (ARC)
01/2013
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
04/2012
1Mood Disorders (Mood Disorder)
02/2012
1Glioma (Gliomas)
11/2010
1Neoplasms (Cancer)
11/2010
1Status Epilepticus (Complex Partial Status Epilepticus)
12/2009
1Epilepsy (Aura)
12/2009
1Gliosis
12/2009
1Congenital Hypothyroidism (Cretinism)
05/2008
1Edema (Dropsy)
05/2007
1Inflammation (Inflammations)
05/2007
1Multiple Sclerosis
06/2005
1Mitochondrial Diseases (Mitochondrial Disease)
01/2005
1Ovarian Neoplasms (Ovarian Cancer)
08/2003

Drug/Important Bio-Agent (IBA)

6Type 7 Cyclic Nucleotide PhosphodiesterasesIBA
02/2020 - 02/2011
5Kainic Acid (Kainate)IBA
10/2016 - 05/2007
4EnzymesIBA
02/2020 - 03/2014
3Pharmaceutical PreparationsIBA
08/2021 - 01/2015
3CCAAT-Enhancer-Binding ProteinsIBA
10/2017 - 02/2015
3Glycogen Synthase Kinase 3IBA
03/2014 - 02/2012
3PPAR gammaIBA
06/2005 - 08/2003
2Adenosine (Adenocard)FDA LinkGeneric
02/2020 - 02/2015
2Proteins (Proteins, Gene)FDA Link
02/2020 - 08/2005
2EndocannabinoidsIBA
01/2017 - 05/2008
2CannabinoidsIBA
01/2017 - 01/2013
2Cannabinoid Receptor AgonistsIBA
01/2017 - 01/2013
2Transcription Factors (Transcription Factor)IBA
02/2015 - 08/2003
2Anti-Inflammatory Agents (Anti-Inflammatories)IBA
02/2015 - 03/2014
2LipopolysaccharidesIBA
02/2011 - 06/2005
2Neuroprotective AgentsIBA
12/2009 - 05/2007
2CCAAT-Enhancer-Binding Protein-betaIBA
04/2008 - 02/2002
2LigandsIBA
01/2005 - 08/2003
1Biomarkers (Surrogate Marker)IBA
01/2020
1Oxidopamine (6 Hydroxydopamine)IBA
10/2017
1Cannabinoid Receptors (Cannabinoid Receptor)IBA
01/2017
1imidazoleIBA
01/2017
1CB1 Cannabinoid Receptor (CB1 Receptor)IBA
01/2017
1AlkaloidsIBA
01/2017
1HU 211 (HU 210)IBA
01/2017
1PDE7 inhibitor S14IBA
06/2015
1Calcium-Binding ProteinsIBA
02/2015
1S100 Calcium-Binding Protein A4IBA
02/2015
1Messenger RNA (mRNA)IBA
02/2015
1Cyclic NucleotidesIBA
02/2015
1Amyloid (Amyloid Fibrils)IBA
01/2015
1Complement System Proteins (Complement)IBA
01/2015
1Glycogen Synthase (Synthase I)IBA
03/2014
1Adenosine Monophosphate (AMP)IBA
03/2014
1Glutamic Acid (Glutamate)FDA Link
09/2012
1QuinazolinesIBA
01/2012
1Ribosomal Protein S6 Kinases (S6 Kinase)IBA
11/2010
14- benzyl- 2- methyl- 1,2,4- thiadiazolidine- 3,5- dioneIBA
11/2010
1Kainic Acid Receptors (Kainate Receptor)IBA
07/2010
1Calcium Channels (Calcium Channel)IBA
12/2009
1Anticonvulsants (Antiepileptic Drugs)IBA
12/2009
1NP 04634IBA
12/2009
1CalciumIBA
12/2009
1TubulinIBA
11/2009
1Electron Transport Complex I (NADH-CoQ Reductase)IBA
08/2009
1tideglusibIBA
05/2007
1Cytotoxins (Cytolysins)IBA
06/2005
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2005
1CaspasesIBA
01/2005
115-deoxy-delta(12,14)-prostaglandin J2IBA
01/2005
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
01/2005
1BRCA1 ProteinIBA
08/2003
1Rosiglitazone (Avandia)FDA Link
08/2003

Therapy/Procedure

2Therapeutics
02/2019 - 06/2015